Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

Gastroenterology

Pharmacology/kinetics

Statin use reduced hepatocellular carcinoma risk in patients with NAFLD

Clinical Gastroenterology and Hepatology | Feb 15, 2022 Pharmacology/kinetics

Guselkumab for the treatment of Crohn disease: Induction results from the phase 2 GALAXI-1 study

Gastroenterology | Feb 12, 2022 Pharmacology/kinetics

Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: A single-arm, open-label, phase 2 trial

The Lancet: Gastroenterology & Hepatology | Feb 12, 2022 Pharmacology/kinetics

Rectal indomethacin to prevent pancreatitis after extracorporeal shock wave lithotripsy (RIPEP): A single-center, double-blind, randomized, placebo-controlled trial

The Lancet: Gastroenterology & Hepatology | Feb 12, 2022 Pharmacology/kinetics

Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT)

Diabetes, Obesity and Metabolism | Feb 12, 2022 Pharmacology/kinetics

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: A randomized, open-label, phase 2 trial

The Lancet: Gastroenterology & Hepatology | Feb 12, 2022 Pharmacology/kinetics

Randomized placebo‐controlled trial of losartan for pediatric nonalcoholic fatty liver disease

Hepatology | Feb 11, 2022 Pharmacology/kinetics

A multicenter phase II trial evaluating the efficacy of bevacizumab plus mFOLFOX6 for R0 surgical resection in advanced colorectal liver metastases harboring mutant-type KRAS: NEXTO-mt trial

HPB | Feb 11, 2022 Pharmacology/kinetics

HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysis

Hepatology | Feb 10, 2022 Pharmacology/kinetics

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis

Gut | Feb 10, 2022 Pharmacology/kinetics

« Prev 1 2 3 4 5 … 85 Next »

Statin use reduced hepatocellular carcinoma risk in patients with NAFLD

Guselkumab for the treatment of Crohn disease: Induction results from the phase 2 GALAXI-1 study

Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: A single-arm, open-label, phase 2 trial

Rectal indomethacin to prevent pancreatitis after extracorporeal shock wave lithotripsy (RIPEP): A single-center, double-blind, randomized, placebo-controlled trial

Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT)

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: A randomized, open-label, phase 2 trial

Randomized placebo‐controlled trial of losartan for pediatric nonalcoholic fatty liver disease

A multicenter phase II trial evaluating the efficacy of bevacizumab plus mFOLFOX6 for R0 surgical resection in advanced colorectal liver metastases harboring mutant-type KRAS: NEXTO-mt trial

HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysis

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis

Gut Health Disorders and its Management

Autoimmune Disorders and its Management

Effect of Hypertension on eyes : MCQ Challenge

Forensic Medicine and Toxicology: An Introduction

MIP: HIV and Pulmonary System: HIV And Non Infectious Pulmonary Diseases: Dr Bhimasena Rao R S

Statin use reduced hepatocellular carcinoma risk in patients with NAFLD

Guselkumab for the treatment of Crohn disease: Induction results from the phase 2 GALAXI-1 study

Neoadjuvant cemiplimab for resectable hepatocellular carcinoma: A single-arm, open-label, phase 2 trial

Rectal indomethacin to prevent pancreatitis after extracorporeal shock wave lithotripsy (RIPEP): A single-center, double-blind, randomized, placebo-controlled trial

Combination therapy with pioglitazone/exenatide/metformin reduces the prevalence of hepatic fibrosis and steatosis: The efficacy and durability of initial combination therapy for type 2 diabetes (EDICT)

Perioperative nivolumab monotherapy versus nivolumab plus ipilimumab in resectable hepatocellular carcinoma: A randomized, open-label, phase 2 trial

Randomized placebo‐controlled trial of losartan for pediatric nonalcoholic fatty liver disease

A multicenter phase II trial evaluating the efficacy of bevacizumab plus mFOLFOX6 for R0 surgical resection in advanced colorectal liver metastases harboring mutant-type KRAS: NEXTO-mt trial

HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta-analysis

Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis

Gut Health Disorders and its Management

Autoimmune Disorders and its Management

Effect of Hypertension on eyes : MCQ Challenge

Forensic Medicine and Toxicology: An Introduction

MIP: HIV and Pulmonary System: HIV And Non Infectious Pulmonary Diseases: Dr Bhimasena Rao R S

Select Specialty

Select Topic